Hashtag
Men's Weekly

Alterity Therapeutics to Participate in the Sachs Associates 6th Annual Neuroscience Innovation Forum

Alterity Therapeutics to Participate in the Sachs Associates 6th Annual Neuroscience Innovation Forum

MELBOURNE, Australia and SAN FRANCISCO, Jan. 3, 2023 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that David Stamler, M.D., Chief Executive Officer will participate in the Sachs Associates 6th Annual Neuroscience Innovation Forum (NIF). The forum is taking place Sunday, January 8, 2022, as part of the activities surrounding the annual J.P. Morgan Healthcare Conference.

At the conference, Dr. Stamler will be featured on a panel entitled, "New Approaches to Parkinson's and Movement Disorders." He will also present a company update and participate in investor and business development meetings.

The program for the 6th Annual NIF is designed to cover the latest developments in global bio-partnering and investment, with additional panels covering scientific advances in key therapeutic areas of neurodegenerative diseases and CNS more broadly, which includes neuropsychiatry, ophthalmology, neurotech and digital therapeutics.

About Alterity Therapeutics Limited

Alterity Therapeutics is a clinical stage biotechnology company dedicated to creating an alternate future for people living with neurodegenerative diseases. The Company's lead asset, ATH434, has the potential to treat various Parkinsonian disorders. Alterity also has a broad drug discovery platform generating patentable chemical compounds to intercede in disease processes. The Company is based in Melbourne, Australia, and San Francisco, California, USA. For further information please visit the Company's web site at www.alteritytherapeutics.com.

 Authorisation & Additional information

This announcement was authorized by David Stamler, CEO of Alterity Therapeutics Limited.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/alterity-therapeutics-to-participate-in-the-sachs-associates-6th-annual-neuroscience-innovation-forum-301712033.html

Authors: PR Newswire

Read more https://www.prnasia.com/story/archive/3976287_CN76287_0

Health & Wellness

Sleep Dentistry for Anxiety: How Modern Treatment Helps Patients Relax

Hashtag.net.au - avatar Hashtag.net.au

For many people, dental anxiety isn’t just a minor worry — it’s a barrier that keeps them from getting the care they need. The sound of drills, the sterile scent, or even a simple check-up can cause h...

How to Choose the Right Earplugs for Sleeping: A Comprehensive Guide

Hashtag.net.au - avatar Hashtag.net.au

Getting a restful night's sleep is essential for overall health and well-being. For many, external noises—be it a snoring partner, traffic, or noisy neighbors—can disrupt sleep patterns. One effective...

How Teen Depression Differs from Normal Adolescent Mood Swings

Hashtag.net.au - avatar Hashtag.net.au

Adolescence is often described as a turbulent period of life. Hormonal changes, social pressures, academic stress, and the search for identity all combine to make the teenage years emotionally inten...